{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:40:42Z","timestamp":1792590042201,"version":"4.5.0"},"reference-count":22,"publisher":"MyJove Corporation","issue":"230","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70596","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:00:36Z","timestamp":1777503636000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Outcomes of Meropenem and Imipenem in Multidrug-Resistant Pulmonary Infections: A Prospective Cohort Study"],"prefix":"10.3791","author":[{"given":"Xue-Mei","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ppul.26152","type":"journal-article","article-title":"Airway multidrug-resistant organisms in a population of tracheostomy and chronic ventilator-dependent children at a tertiary care pediatric hospital","volume":"58","author":"Havens","year":"2023","unstructured":"Havens, T. N. et al. Airway multidrug-resistant organisms in a population of tracheostomy and chronic ventilator-dependent children at a tertiary care pediatric hospital. Pediatr Pulmonol. 58 (1), 26-34 (2023).","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"ref2","first-page":"3309","type":"journal-article","article-title":"The drug resistance of multidrug-resistant bacterial organisms in pediatric pneumonia patients","volume":"13","author":"Chen","year":"2021","unstructured":"Chen, X. et al. The drug resistance of multidrug-resistant bacterial organisms in pediatric pneumonia patients. Am J Transl Res. 13 (4), 3309-3315 (2021).","journal-title":"Am J Transl Res"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jmii.2022.02.001","type":"journal-article","article-title":"Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms","volume":"55","author":"Sy","year":"2022","unstructured":"Sy, C. L. et al. Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms. J Microbiol Immunol Infect. 55 (3), 359-386 (2022).","journal-title":"J Microbiol Immunol Infect"},{"issue":"21","key":"ref4","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.scib.2023.09.040","type":"journal-article","article-title":"\u201cSuperbugs\u201d with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China","volume":"68","author":"Pu","year":"2023","unstructured":"Pu, D. et al. \u201cSuperbugs\u201d with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China. Sci Bull (Beijing). 68 (21), 2658-2670 (2023).","journal-title":"Sci Bull (Beijing)"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s11739-021-02749-1","type":"journal-article","article-title":"Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections","volume":"16","author":"Matlock","year":"2021","unstructured":"Matlock, A. et al. Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections. Intern Emerg Med. 16 (8), 2231-2241 (2021).","journal-title":"Intern Emerg Med"},{"key":"ref6","first-page":"1","type":"journal-article","article-title":"Advancement of pharmaceutical nanomedicines: From laboratory to commercialization","volume":"76","author":"Nswadi","year":"2025","unstructured":"Nswadi, N. Advancement of pharmaceutical nanomedicines: From laboratory to commercialization. Int J Clin Med Res. 76, 1-12 (2025).","journal-title":"Int J Clin Med Res"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.mcna.2025.01.003","type":"journal-article","article-title":"Management of severe infections: Multidrug-resistant and carbapenem-resistant gram-negative bacteria","volume":"109","author":"Perez","year":"2025","unstructured":"Perez, F. et al. Management of severe infections: Multidrug-resistant and carbapenem-resistant gram-negative bacteria. Med Clin North Am. 109 (3), 735-747 (2025).","journal-title":"Med Clin North Am"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/antibiotics13050416","type":"journal-article","article-title":"Comparative in vitro activity of ceftazidime-avibactam, imipenem-relebactam, and meropenem-vaborbactam against carbapenem-resistant clinical isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa","volume":"13","author":"Sophonsri","year":"2024","unstructured":"Sophonsri, A. et al. Comparative in vitro activity of ceftazidime-avibactam, imipenem-relebactam, and meropenem-vaborbactam against carbapenem-resistant clinical isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa. Antibiotics (Basel). 13 (5), 416 (2024).","journal-title":"Antibiotics (Basel)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e2519690","DOI":"10.1080\/14656566.2025.2519690","type":"journal-article","article-title":"Tackling multidrug-resistant gram-negative infections in children globally: current therapeutic options and perspectives","volume":"26","author":"Chiusaroli","year":"2025","unstructured":"Chiusaroli, L. et al. Tackling multidrug-resistant gram-negative infections in children globally: current therapeutic options and perspectives. Expert Opin Pharmacother. 26, e2519690 (2025).","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/14656566.2020.1840552","type":"journal-article","article-title":"An evaluation of meropenem\/vaborbactam for the treatment of nosocomial pneumonia","volume":"22","author":"Groft","year":"2021","unstructured":"Groft, L. M. et al. An evaluation of meropenem\/vaborbactam for the treatment of nosocomial pneumonia. Expert Opin Pharmacother. 22 (3), 265-271 (2021).","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/SHK.0000000000001599","type":"journal-article","article-title":"Early screening of risk for multidrug-resistant organisms in the emergency department in patients with pneumonia and early septic shock","volume":"55","author":"Yiang","year":"2021","unstructured":"Yiang, G. T. et al. Early screening of risk for multidrug-resistant organisms in the emergency department in patients with pneumonia and early septic shock. Shock. 55 (2), 198-209 (2021).","journal-title":"Shock"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7268519","DOI":"10.1155\/2020\/7268519","type":"journal-article","article-title":"Risk factors of multidrug-resistant bacteria in lower respiratory tract infections: a systematic review and meta-analysis","volume":"2020","author":"Chen","year":"2020","unstructured":"Chen, G. et al. Risk factors of multidrug-resistant bacteria in lower respiratory tract infections: a systematic review and meta-analysis. Can J Infect Dis Med Microbiol. 2020, 7268519 (2020).","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.xphs.2022.01.015","type":"journal-article","article-title":"Population pharmacokinetics analysis and dosing simulations of Meropenem in critically ill patients with pulmonary infection","volume":"111","author":"Lan","year":"2022","unstructured":"Lan, J. et al. Population pharmacokinetics analysis and dosing simulations of Meropenem in critically ill patients with pulmonary infection. J Pharm Sci. 111 (6), 1833-1842 (2022).","journal-title":"J Pharm Sci"},{"issue":"5","key":"ref14","first-page":"140","type":"journal-article","article-title":"The effectiveness of advanced verbal counseling in managing adults\u2019 asthma at various severity levels","volume":"3","author":"Mohamed","year":"2025","unstructured":"Mohamed, B. et al. The effectiveness of advanced verbal counseling in managing adults\u2019 asthma at various severity levels. Int J Clin Med Res. 3 (5), 140-147 (2025).","journal-title":"Int J Clin Med Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1253623","DOI":"10.3389\/fmicb.2023.1253623","type":"journal-article","article-title":"Imipenem heteroresistance but not tolerance in Haemophilus influenzae during chronic lung infection associated with chronic obstructive pulmonary disease","volume":"14","author":"Gil-Campillo","year":"2023","unstructured":"Gil-Campillo, C. et al. Imipenem heteroresistance but not tolerance in Haemophilus influenzae during chronic lung infection associated with chronic obstructive pulmonary disease. Front Microbiol. 14, 1253623 (2023).","journal-title":"Front Microbiol"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"e4539","DOI":"10.1093\/cid\/ciaa803","type":"journal-article","article-title":"Imipenem\/cilastatin\/relebactam versus piperacillin\/tazobactam in hospital-acquired and ventilator-associated bacterial pneumonia (RESTORE-IMI 2)","volume":"73","author":"Titov","year":"2021","unstructured":"Titov, I. et al. Imipenem\/cilastatin\/relebactam versus piperacillin\/tazobactam in hospital-acquired and ventilator-associated bacterial pneumonia (RESTORE-IMI 2). Clin Infect Dis. 73 (11), e4539-e4548 (2021).","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10096-021-04388-y","type":"journal-article","article-title":"Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high-dose Meropenem: a case report","volume":"41","author":"Arcari","year":"2022","unstructured":"Arcari, G. et al. Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high-dose Meropenem: a case report. Eur J Clin Microbiol Infect Dis. 41 (3), 495-500 (2022).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"e0383623","DOI":"10.1128\/spectrum.03836-23","type":"journal-article","article-title":"In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp","volume":"12","author":"Santerre Henriksen","year":"2024","unstructured":"Santerre Henriksen, A. et al. In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp. Microbiol Spectr. 12 (4), e0383623 (2024).","journal-title":"Microbiol Spectr"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e2412014","DOI":"10.4014\/jmb.2412.12014","type":"journal-article","article-title":"Yinhua Pinggan granules combined with Meropenem alleviate lung injury induced by multidrug-resistant Klebsiella pneumoniae via NF-\u03baB and NLRP3 inflammasome inhibition","volume":"35","author":"Zhang","year":"2025","unstructured":"Zhang, S. et al. Yinhua Pinggan granules combined with Meropenem alleviate lung injury induced by multidrug-resistant Klebsiella pneumoniae via NF-\u03baB and NLRP3 inflammasome inhibition. J Microbiol Biotechnol. 35, e2412014 (2025).","journal-title":"J Microbiol Biotechnol"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1093\/jac\/dkab286","type":"journal-article","article-title":"Meropenem concentrations in brain tissue of neurointensive care patients exceed cerebrospinal fluid levels","volume":"76","author":"Hosmann","year":"2021","unstructured":"Hosmann, A. et al. Meropenem concentrations in brain tissue of neurointensive care patients exceed cerebrospinal fluid levels. J Antimicrob Chemother. 76 (11), 2914-2922 (2021).","journal-title":"J Antimicrob Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"781892","DOI":"10.3389\/fphar.2021.781892","type":"journal-article","article-title":"Maximizing Css\/MIC ratio improves efficacy of continuous infusion meropenem in critically ill patients","volume":"12","author":"Cojutti","year":"2021","unstructured":"Cojutti, P. G. et al. Maximizing Css\/MIC ratio improves efficacy of continuous infusion meropenem in critically ill patients. Front Pharmacol. 12, 781892 (2021).","journal-title":"Front Pharmacol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.61466\/ijcmr3030004","type":"journal-article","article-title":"Performance of breath-actuated Qvar pressurized metered-dose inhaler with different spacers: an in vitro study","volume":"3","author":"Almeziny","year":"2025","unstructured":"Almeziny, M. et al. Performance of breath-actuated Qvar pressurized metered-dose inhaler with different spacers: an in vitro study. Int J Clin Med Res. 3 (3), 77-86 (2025).","journal-title":"Int J Clin Med Res"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/70596\/comparative-outcomes-meropenem-imipenem-multidrug-resistant-pulmonary","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:54:43Z","timestamp":1792587283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70596\/comparative-outcomes-meropenem-imipenem-multidrug-resistant-pulmonary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":22,"journal-issue":{"issue":"230","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70596","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}